Clinical trial · Interventional
Benefits of Formalized Care Support Program Following Acute Leukemia Diagnosis
Benefits of Formalized Care Support Program Following an Annoucement of Acute Leukemia Diagnosis
NCT07499765CI-TRIAL-00109738ANX-LArecruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to determine the impact on anxiety between patients with a period of care support following their announcement of an acute leukemia (AL) diagnosis and patients without this accompaniment.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Acute Leukemia | Acute Leukemia | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| care support program after diagnosis announcement | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- NO_INTERVENTION
- label
- Standard arm
- description
- After randomization and diagnosis announcement, patient will be followed as usually
- type
- EXPERIMENTAL
- label
- Experimental arm
- description
- After randomization and diagnosis announcement, patient will have dedicated time with a nurse to explain in detail the diagnosis, the treatment. The anxiety will be also evaluated at different timepoints
- interventionNames
- Other: care support program after diagnosis announcement
Primary outcomes (1)
- measure
- Anxiety improvment
- timeFrame
- 7 days after diagnosis announcement
- description
- variation of anxiety level using STAI questionnaire
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 26 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * informed consent signed * medical confirmation of acute leukemia diagnosis * age equal of superior to 26 years and under 80 years * confirmed diagnosis not yet treated * hospitalization at Centre Henri Becquerel * member or beneficiary of a social security Exclusion Criteria: * -Patient unable to understand the study for any reason or to comply with the trial's requirements * Patient in relapse of acute leukemia * Patient diagnosed with acute myeloid leukemia 3 * History of cancer within the 5 years preceding the year of study enrollment * Alcohol and drug abuse * Inclusion in another therapeutic trial that prevents further enrollment in a trial evaluating quality of life or psychological well-being * Diagnosed psychiatric illness * Patient under guardianship, curatorship, or legal protection
References
Publications (0)
Data not yet available
No reference posted for this study.